Evidence review · standard

melanotan ii

bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects (paste without context)

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `melanotan-ii`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/melanotan-ii

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/melanotan-ii/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Paste-ready package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/melanotan-ii/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/melanotan-ii/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/melanotan-ii/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

*Not medical advice. Tier-honest. Cite claim/source ids.*

Regeneration vs degeneration — where this fits

The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.

What it is

2026 case report documenting oral mucosal pigmentation changes following Melanotan II use, with follow-up observations on resolution after discontinuation. 2025 case report linking Melanotan II nasal spray use to oral mucosal malignant melanoma in a young female; highlights unlicensed status and need for awareness of serious side effects.

How it works

Step logic:

  1. 2025 case report linking Melanotan II nasal spray use to oral mucosal malignant melanoma in a young female; highlights unlicensed status and need for awareness of serious side effects.

Why it would work (logic chain)

  1. IF 2025 case report linking Melanotan II nasal spray use to oral mucosal malignant melanoma in a young female; highlights unlicensed status and need for awareness of serious side effects. THEN that is one proposed link in a repair/regeneration pathway (not yet proven end-to-end in humans unless a human claim says so).
  2. IF 2026 case report documenting oral mucosal pigmentation changes following Melanotan II use, with follow-up observations on resolution after discontinuation. THEN that is one proposed link in a repair/regeneration pathway (not yet proven end-to-end in humans unless a human claim says so).
  3. IF May 2026 listing of ongoing Phase 2 RCT (NCT07437560) testing MT-II safety and efficacy as add-on to phototherapy for vitiligo repigmentation. THEN that is one proposed link in a repair/regeneration pathway (not yet proven end-to-end in humans unless a human claim says so).
  4. IF 2026 case report of multiple primary melanomas in situ associated with recent Melanotan (II) exposure along with other risk factors. THEN that is one proposed link in a repair/regeneration pathway (not yet proven end-to-end in humans unless a human claim says so).

How many people take it

There is no reliable global count of how many people take this compound. That number is not in this ledger.

What we can count from this ledger:

  • 0 anecdote source(s) (posts, threads, comments)
  • 0 anecdote-tier claim(s) derived from them

Logic: Without catalogued Reddit/X posts, this article cannot answer how many people take it — only what studies exist.

Evidence inventory

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 4
  • Claims tagged human evidence: 3
  • Claims tagged preclinical (animal/lab): 0
  • Claims tagged anecdotal: 0
  • Reddit posts catalogued: 0
  • X posts catalogued: 0
  • Other anecdote sources (YouTube, Instagram, etc.): 0
  • Total sources in chain: 4

Logic: No social posts catalogued yet — we cannot report what people are saying on Reddit or X from this ledger.

Quantified confidence (this ledger): 0.46 / 1.00 — low–moderate — mostly preclinical

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

Melanotan II nasal spray: a possible risk factor for oral mucosal malignant melanoma? (source s1)

2025 case report linking Melanotan II nasal spray use to oral mucosal malignant melanoma in a young female; highlights unlicensed status and need for awareness of serious side effects.

Evidence type: Published research.

Melanotan II (MT-II) as an Adjunct to NB-UVB Phototherapy for Repigmentation in Stable Nonsegmental Vitiligo (source s2)

May 2026 listing of ongoing Phase 2 RCT (NCT07437560) testing MT-II safety and efficacy as add-on to phototherapy for vitiligo repigmentation.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Five primary melanomas in situ in a patient with recent tanning bed use, melanotan exposure, and anabolic hormone use (source s3)

2026 case report of multiple primary melanomas in situ associated with recent Melanotan (II) exposure along with other risk factors.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Changes in Oral Mucosa Associated with Melanotan II Injections: A Case Report (source s4)

2026 case report documenting oral mucosal pigmentation changes following Melanotan II use, with follow-up observations on resolution after discontinuation.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

Melanotan Ii · peptide map

Evidence map

Hover a node — its path lights up. Click to open the article.

Full map →
JumpBenzo WithdrawalBenzodiazepinesBrain FogCarpal Tunnel
Evidence · 4 sources · swipe →chain bde45647758f · verify chain · provenance
1 / 4
Evidence ledger 4 · tier-ranked · API
human
2026 case report documenting oral mucosal pigmentation changes following Melanotan II use, with follow-up observations on resolution after discontinuation.
sources: s4
mechanistic
2025 case report linking Melanotan II nasal spray use to oral mucosal malignant melanoma in a young female; highlights unlicensed status and need for awareness of serious side effects.
sources: s1
human
May 2026 listing of ongoing Phase 2 RCT (NCT07437560) testing MT-II safety and efficacy as add-on to phototherapy for vitiligo repigmentation.
sources: s2
human
2026 case report of multiple primary melanomas in situ associated with recent Melanotan (II) exposure along with other risk factors.
sources: s3
Model swipes · 3 from 1 model · swipe →verify
1 / 3
grok-4.3writer
draft2026-06-29 17:07
melanotan ii
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: melanotan-ii
it output
1 source(s) added
21bf311941691077
grok-4.3source_hunt
sources2026-06-29 17:07
3 source(s) added · 3 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: melanotan-ii
it output
1 source(s) added
0a81d7a1ed39c58d
grok-4.3source_hunt
sources2026-06-29 17:07
1 source(s) added · 1 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: melanotan-ii
it output
1 source(s) added
89ae4b9beda9ccc2

Related research

Melanotan Ii · peptide map

Open evidence map →
Benzo Withdrawalmelanotan-ii-benzo-withdrawalBenzodiazepinesmelanotan-ii-benzodiazepinesBrain Fogmelanotan-ii-brain-fogCarpal Tunnelmelanotan-ii-carpal-tunnelChemomelanotan-ii-chemoChemo Neuropathymelanotan-ii-chemo-neuropathyCognitionmelanotan-ii-cognitionCorticosteroidsmelanotan-ii-corticosteroidsDiabetic Neuropathymelanotan-ii-diabetic-neuropathyFrozen Shouldermelanotan-ii-frozen-shoulder
Ask this article · 6 suggested prompts
topology · JSON · question graph

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (human tier): "May 2026 listing of ongoing Phase 2 RCT (NCT07437560) testing MT-II safety and efficacy as add-on to phototherapy for vitiligo repigmentatio…"?
ask melanotan-ii claim c2 · paste includes §SELF
What does the ledger say about this (human tier): "2026 case report documenting oral mucosal pigmentation changes following Melanotan II use, with follow-up observations on resolution after d…"?
ask melanotan-ii claim c4 · paste includes §SELF
What does the ledger say about this (mechanistic tier): "2025 case report linking Melanotan II nasal spray use to oral mucosal malignant melanoma in a young female; highlights unlicensed status and…"?
ask melanotan-ii claim c1 · paste includes §SELF
What does the ledger say about this (human tier): "2026 case report of multiple primary melanomas in situ associated with recent Melanotan (II) exposure along with other risk factors."?
ask melanotan-ii claim c3 · paste includes §SELF
For my medical situation, what can you answer from your catalogue about melanotan ii — and what would you need me to tell you first?
ask melanotan-ii condition gaps · paste includes §SELF
What good and bad outcomes are documented for melanotan ii (studies vs anecdotes)?
ask melanotan-ii good bad experiences · paste includes §SELF
melanotan-ii · posted 2026-06-29 · updated 2026-06-29 · 2 prior revisions
Ledger API & provenance
Provenance · 3 model passes · 0 tokens · $0 · 1 model
chain head 361071670c49360e
populate-init grok-4.3 · 2026-06-29 17:07 · 0 tok · 5a75909be61a
sources grok-4.3 · 2026-06-29 17:07 · 0 tok · 2a50faab244d
sources grok-4.3 · 2026-06-29 17:07 · 0 tok · 361071670c49
verify chain →
REST + ledger
read GET /api/articles/melanotan-ii · GET /api/articles/melanotan-ii?format=post (the editable body)
create/replace POST /api/articles/melanotan-ii · PUT /api/articles/melanotan-ii (replace, keeps revision) · PATCH /api/articles/melanotan-ii (merge)
delete DELETE /api/articles/melanotan-ii
writes need header x-terminal-key
ledger provenance · sources · contributions · revisions · live ledger & cards
LLM bundle GET /api/articles/melanotan-ii/bundle?format=markdown — body + claims + sources + provenance + manifest
voxel graph GET /api/articles/melanotan-ii/voxels · constitution · ontology
post claim POST /api/protocol/claim · iMessage claim melanotan-ii|tier|assertion
system map GET /api/articles/system-map?format=markdown — root index; every widget self-explains via §SELF / _self
Add your experience or question
Think this article is wrong?
Call bullshit on CharlieOS →